Dennis Padla, MD
Psychiatry · Stevensville, MINPI 1295728921
Payments from drug & device makers
Across 81 payments — averaging $44.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- Johnson & Johnson$567
- Otsuka America Pharmaceutical, Inc.$541
- Teva Pharmaceuticals USA, Inc.$249
- Axsome Therapeutics, Inc.$244
- AbbVie$190
- plus $812 from 11 others
What the payments were for
- Food & beverage$3,47696%
- Education$1474%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 20 | $1,020 |
| Johnson & Johnson | 14 | $567 |
| Otsuka America Pharmaceutical, Inc. | 21 | $541 |
| Teva Pharmaceuticals USA, Inc. | 3 | $249 |
| Axsome Therapeutics, Inc. | 2 | $244 |
| AbbVie | 5 | $190 |
| Novo Nordisk | 3 | $144 |
| Neurocrine Biosciences, Inc. | 2 | $144 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Acadia Pharmaceuticals Inc | 1 | $112 |
| Janssen Scientific Affairs, LLC | 1 | $98 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $77 |
| Almatica Pharma LLC | 1 | $31 |
| Sage Therapeutics, LLC | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$2,087
- Auvelity$244
- ARISTADA$231
- REXULTI$230
- Wegovy$125
- COBENFY$125
- INGREZZA$122
- Austedo XR$117
- ARISTADA INITIO$116
- NUPLAZID$112
- VRAYLAR$109
- INVEGA SUSTENNA$107
- SPRAVATO$103
How this compares
$3,623 in reported general payments places this provider in the 85th percentile of 1,166 psychiatry providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 37 | $287,040 |
| VraylarCariprazine Hcl | 72 | $103,280 |
| Invega SustennaPaliperidone Palmitate | 18 | $50,365 |
| CaplytaLumateperone Tosylate | 20 | $36,167 |
| AuvelityDextromethorphan Hbr/Bupropion | 24 | $30,212 |
| Lurasidone Hcl | 53 | $29,228 |
| LybalviOlanzapine/Samidorphan Malate | 16 | $24,829 |
| Clozapine | 183 | $16,634 |
| Aripiprazole | 122 | $10,572 |
| Olanzapine | 151 | $5,716 |
| Methylphenidate ErMethylphenidate Hcl | 23 | $4,881 |
| Divalproex Sodium ErDivalproex Sodium | 30 | $2,660 |
| Quetiapine Fumarate | 129 | $2,248 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 22 | $2,044 |
| Prazosin Hcl | 75 | $1,936 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $144 | $287,04037 claims |
| AbbVieVraylar | $190 | $103,28072 claims |
| Johnson & JohnsonInvega Sustenna | $567 | $50,36518 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $77 | $36,16720 claims |
| Axsome Therapeutics, Inc.Auvelity | $244 | $30,21224 claims |
| Alkermes, Inc.Lybalvi | $1,020 | $24,82916 claims |
| Lilly USA, LLCOlanzapine | $23 | $5,716151 claims |
| Almatica Pharma LLCSertraline Hcl | $31 | $499135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,166 psychiatry providers in Michigan.
Other psychiatry in Stevensville
- Andreas SidiropoulasDetroit$2.8M
- Joel YoungRochester Hills$1.9M
- Welton WashingtonYpsilanti$1.4M
- Rajaprabhakaran RajarethinamAnn Arbor$1.2M
- Eric AchtyesGrand Rapids$705K
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Brian MickeyAnn Arbor$490K
- Sagar ParikhAnn Arbor$331K
- Robert LagrouClarkston$267K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.